| Technical Name | Pharmaceutical Composition Against Influenza Virus Containing Sanguisorba officinalis L. | ||
|---|---|---|---|
| Project Operator | National Defense Medical Center | ||
| Project Host | |||
| Summary | The present invention relates to a pharmaceutical composition against influenza virus. The pharmaceutical composition comprises a therapeutically effective amount of the extract of Sanguisorba officinalis L., or active compounds obtained from the extract of S. officinalis and the corresponding hydrolyzed compound. |
||
| Scientific Breakthrough | The present invention relates to a pharmaceutical composition against influenza virus. The pharmaceutical composition comprises a therapeutically effective amount of the extract of Sanguisorba officinalis L., or active compounds obtained from the extract of S. officinalis and the corresponding hydrolyzed compound. |
||
| Industrial Applicability | 本發明提供全新選擇之藥物或健康食品，對於抗流感具有高效、毒性低、量產容易且成本低廉等優特點，適合國內生醫科技產業發展。 |
||
| Keyword | |||
| Notes | |||
- Contact
other people also saw